Home Pharmaceuticals Effervescent Tablet Market Size to Reach US $15.56 billion by 2031

Effervescent tablet Market

Effervescent tablet Market Size, Share & Trends Analysis Report By Products (Medication, Supplements), By Methods (Dry Methods, Wet Granulation), By Type (Prescription, Over the Counter), By Indication (Diuretics, Pain Management,, Gastric Disorders, Respiratory Diseases, Others), By Population Type (Children, Adults), By Application (Dental Products, Dietary Supplements, Pharmaceutical, Others), By End User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Retail Pharmacies, Drug Store, E-Commerce, Hypermarkets and Supermarkets, MLM ) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54789DR
Study Period 2019-2031 CAGR 7.2%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 8.32 Billion
Forecast Year 2031 Forecast Year Market Size USD 15.56 Billion
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global effervescent tablet market size was valued at USD 8.32 billion in 2022 and is projected to reach USD 15.56 billion by 2031, registering a CAGR of 7.2% during the forecast period (2023-2031).

Effervescent tablets dissolve quickly in water or another liquid, emitting carbon dioxide. Because the pill is quickly broken down, it dissolves into a frothy or fizzy solution. These tablets can be used to give a wide range of medications. These pills have several advantages. The tablets immediately transport pharmaceuticals to the body because the prescriptions are delivered as a rapidly absorbed solution.

Effervescent tablet market share is attributed to several factors contributing to the popularity and growth of effervescent tablets in various industries, such as convenience, increasing demand for dietary supplements, pharmaceutical applications, and the rising OTC market. When ingested in large quantities, some effervescent pills cause adverse effects rather than cures, limiting the market's growth. Effervescent tablets are expensive to manufacture, directly influencing their price, which is out of reach for many people, limiting the growth of the global effervescent tablet market.


  • Prescription type holds the major share in the market based on type. 
  • Supplements influenced the market based on product.
  • The dry method is the most used method based on the method.
  • Pain Management is the highest contributor based on the indication.
  • The adult segment owns the major share based on population type.
  • Dental products are the highest shareholder based on application.
  • Hospitals led the market based on end-user.
  • Retail pharmacies topped the market based on distribution channels.
  • North America dominates the market.

Market Dynamics

Market Drivers

Growing Demand for Dietary Supplements

Vitamin C is a well-known nutritional vitamin with immune-boosting qualities. Because of their pleasant flavor and ease of administration, effervescent vitamin C pills have grown in favor among consumers. Effervescent vitamin C tablets are popular over standard vitamin C tablets or capsules because they may be dissolved in water to make a delicious and effervescent drink. Multivitamins are well-known nutritional supplements that include a variety of vitamins and minerals. Effervescent multivitamin pills provide a complete approach to satisfying daily nutritional needs in a handy and pleasurable way. According to the Council for Responsible Nutrition's 2021 Annual Survey on Dietary Supplements, dietary supplement use in the United States has hit an all-time high. According to the poll, 76% of U.S. people will use dietary supplements in 2021, up from 74% the previous year. This data demonstrates the growing interest in and dependence on dietary supplements to promote overall health and wellness. Thereby driving the effervescent tablet market growth.

Market Restraints

High Production Cost

Several variables, including the need for specialized equipment, precise ingredient control, and additional packaging needs, cause the high production costs of effervescent tablets. The manufacturing process may include several processes, such as granulation, mixing, tablet compression, and packing, each adding to the final cost. Manufacturing pharmaceutical and nutraceutical goods, particularly effervescent tablets, entails a variety of expenditures associated with raw ingredients, equipment, personnel, quality control, and regulatory compliance. When compared to typical dosage forms, the complexity of the effervescent tablet manufacturing process and the necessity for specialized equipment might contribute to higher production costs. According to a study published in the journal 'Pharmaceuticals,' the cost of producing effervescent tablets may be higher than the cost of producing other solid dosage forms, such as conventional tablets or capsules, due to the additional processing steps involved in producing the effervescent reaction and ensuring the tablet disintegration.

Market Opportunities

Innovation in Product Formulation

Effervescent tablet formulation innovation enables producers to precisely blend numerous vitamins and minerals to customize solutions to certain health issues or demographic groups. Formulations aimed at children, for example, may have greater quantities of vitamins that promote growth and development. In contrast, formulations aimed at older persons may concentrate on vitamins and minerals that promote bone health and cognitive function. Furthermore, effervescent tablets allow adding functional components, such as herbal extracts, amino acids, antioxidants, or electrolytes, to boost the product's health benefits. These formulations offer a distinct marketing point, attracting customers seeking full health assistance in a single, easy dose form. Manufacturers may capitalize on consumer preferences for fun and delicious supplements by providing a variety of tastes, such as fruity, citrusy, or herbal alternatives. By customizing the flavor profile, producers may appeal to a wider range of taste preferences, making effervescent multivitamins and mineral pills more acceptable to a wider customer base. Finally, the prospect for product formulation innovation is a crucial market driver.

Regional Analysis

The global effervescent tablet market research is analyzed in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America Dominates the Global Market

North America is expected to lead the effervescent tablet market at a CAGR of 6.85% during the projected period. The increased frequency of chronic illnesses and the existence of key market participants are attributed to regional growth. According to CDC data, 1,603,844 new cancer cases were reported in the United States in 2020, with 602,347 cancer-related fatalities documented. For every 100,000 people, there were 403 new cases of cancer and 144 cancer-related deaths. The FDA regulates dietary supplements and pharmaceuticals. Dietary supplements, especially effervescent pills, must follow FDA regulations. FDA rules protect product safety and quality, which affects North American market access and growth. Furthermore, the region's expanding elderly population and innovative product releases drive market revenue. 

Asia-Pacific is a significant market and is expected to grow at a CAGR of 7.56%. The rising health consciousness among the population in the Asia Pacific is predicted to expand at the fastest CAGR throughout the projection period. The populace in the region has become more health concerned and aware. Consumers are becoming more proactive in their health management and seeking preventative healthcare options, such as dietary supplements. Effervescent pills are a handy and fun way to take vitamins, and they align with the rising demand for health and wellness goods. The China Food and Drug Administration (CFDA), the Ministry of Health and Family Welfare in India, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan regulate dietary supplements and pharmaceuticals, including effervescent tablets. To ensure product safety and quality, manufacturers must follow these laws.

Europe is home to numerous industrialized nations with a high degree of health and wellness consciousness, which has increased demand for nutritional supplements and pharmaceutical items, including effervescent tablets. Due to their huge populations and high discretionary income levels, Germany and the United Kingdom are among Europe's main markets for effervescent pills. Other European nations, such as France, Italy, Spain, and the Netherlands, also see increased demand for effervescent pills. The European pharmaceutical market is one of the world's largest. The European Federation of Pharmaceutical Industries and Associations (EFPIA) estimates that the European pharmaceutical industry will be worth around EUR 210 billion in 2020. Effervescent tablets are gaining traction in this sector because of their potential to increase patient compliance and drug administration for certain drugs.

The region of Latin America, the Middle East and Africa includes a wide range of countries with differing levels of development in healthcare infrastructure and distribution networks. Manufacturers may confront difficulties in getting their products to rural or underdeveloped locations. Building strong distribution channels and overcoming logistical hurdles are critical to realizing the region's full market potential for effervescent tablets.

Report Scope

Report Metric Details
By Products
  1. Medication
  2. Supplements
By Methods
  1. Dry Methods
  2. Wet Granulation
By Type
  1. Prescription
  2. Over the Counter
By Indication
  1. Diuretics
  2. Pain Management,
  3. Gastric Disorders
  4. Respiratory Diseases
  5. Others
By Population Type
  1. Children
  2. Adults
By Application
  1. Dental Products
  2. Dietary Supplements
  3. Pharmaceutical
  4. Others
By End User
  1. Hospitals
  2. Homecare
  3. Specialty Clinics
  4. Others
By Distribution Channel
  1. Retail Pharmacies
  2. Drug Store
  3. E-Commerce
  4. Hypermarkets and Supermarkets
  5. MLM 
Company Profiles Bayer AG Bristol-Myers Squibb Company Novartis AG Pfizer Inc. Perrigo Company plc Reckitt Benckiser Group PLC GSK plc CHIESI SAS Hermes Pharma S. G. Biopharm Pvt. Ltd Bliss GVS Pharma Limited Alpex Vovantis Laboratories Swisse Wellness PTY LTD Herbalife International of America Inc. SciTech Nuun Natur Produkt Zdrovit Sp Z O O Vitabiotics Ltd
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global effervescent tablet market is segmented based on type, product, method, indication, population type, application, end-user, distribution channel, and region.

For better understanding type is further segmented into Prescription and daily used tablets.

Prescription type holds the major share of the market. Prescription medications require a medical prescription to treat certain medical disorders. These tablets contain active pharmaceutical ingredients (APIs) designed to give precise and regulated medicine doses. Prescription effervescent pills are often used for long-term treatment of chronic disorders such as hypertension, diabetes, and cardiovascular disease. They are prescribed by healthcare experts such as physicians and specialists and distributed by pharmacies. 

By product, the market is bifurcated into medication and supplements.

Supplements influenced the market growth. Over-the-counter (OTC) supplements contain vitamins, minerals, herbal extracts, and other nutrients. These pills are not designed to treat medical disorders but to be used as dietary supplements to improve overall health and well-being. Supplement effervescent pills can be acquired without a prescription from retail stores, pharmacies, and internet platforms.

The segment is categorized into Dry method and wet granulation based on the method.

The dry method is the most used in the market. The dry method of producing effervescent pills combines active and inactive components in a dry condition. To create a consistent distribution of the components, the dry ingredients are often combined mechanically, such as mixing or tumbling. A tablet press is compressed into a tablet shape when the mixture is homogeneous. After that, the crushed tablets may be coated to increase their stability, flavor, or appearance.

Diuretics, pain management, gastric disorders, respiratory diseases, and others are the sub-segments based on indications.

Pain Management is the highest contributor in the market. Analgesics such as acetaminophen or aspirin may be used in effervescent tablets for pain management. They are designed to give immediate relief from pain and discomfort. These pills are designed to give immediate relief from pain and suffering caused by various diseases. Dissolve the tablet in water to make a pleasant, fizzy solution, making it a more pleasurable and easy choice for people who have trouble swallowing conventional pills or capsules.

By population type, the market is further segmented into adults and children.

The adult segment owns the major share of the market. Adults are designed to meet the unique healthcare demands of the adult population. These pills may include active substances used to treat various adult health issues. Pain treatments, nutritional supplements, antacids, vitamins, and minerals are examples of formulations. Adult effervescent pills are intended to meet the health and well-being requirements of those over 18.

The segment can be bifurcated by application into dental products, dietary supplements, pharmaceuticals, and others.

Dental Products is the highest shareholder in the market. Dental products address oral cleanliness and care. These tablets may include active components such as antibacterial agents, fluoride, or enzymes to promote dental health. When dental effervescent tablets are dissolved in water, they produce a solution that may be used for mouth rinses or dental irrigation, giving an easy and refreshing approach to maintaining oral hygiene.

The end-user segment is further bifurcated into hospitals, home care, specialty clinics, etc.

Hospitals led the market. Effervescent tablets are commonly used in hospitals, where healthcare workers can provide them to patients suffering from various medical ailments. Effervescent tablets for pain management, fever reduction, hydration, and particular medicinal indications are frequently used in hospitals. In hospitals, effervescent tablets provide simplicity of administration and rapid drug delivery, making them ideal for patients who have difficulties swallowing or require fast-acting drugs.

A distribution channel is further segmented into retail pharmacies, drug stores, e-commerce, hypermarkets and supermarkets, and multi-level marketing channels.

Retail pharmacies topped the market. Retail pharmacies, often called community pharmacies or neighborhood drugstores, are important in distributing effervescent pills. These pharmacies are conveniently positioned in neighborhoods and communities, making them accessible to customers. Patients at retail pharmacies can obtain prescription drugs and over-the-counter effervescent pills under the supervision of pharmacists.

Market Size By Products

Recent Developments

Top Key Players

Bayer AG Bristol-Myers Squibb Company Novartis AG Pfizer Inc. Perrigo Company plc Reckitt Benckiser Group PLC GSK plc CHIESI SAS Hermes Pharma S. G. Biopharm Pvt. Ltd Bliss GVS Pharma Limited Alpex Vovantis Laboratories Swisse Wellness PTY LTD Herbalife International of America Inc. SciTech Nuun Natur Produkt Zdrovit Sp Z O O Vitabiotics Ltd Others

Frequently Asked Questions (FAQs)

What is the market size of the Effervescent Tablet Market?
The global effervescent tablet market was worth USD 8.32 billion in 2022 and is expected to reach USD 15.56 billion by 2031, growing 7.2%.
North America is expected to lead the effervescent tablet market at a CAGR of 6.85% during the projected period.
The major players in the global effervescent tablet market are Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Perrigo Company plc, Reckitt Benckiser Group PLC, GSK plc, CHIESI SAS, Hermes Pharma, S. G. Biopharm Pvt. Ltd, Bliss GVS Pharma Limited, Alpex, Vovantis Laboratories.
By product, the market is bifurcated into medication and supplements.

We are featured on :